• Search Faculty Directory Again
  • Photo: Michael S Kent

    Michael S Kent- BA, DVM, MAS
    Professor and Researcher
    Surgical & Radiological Sciences

    137 CCAH
    Davis, CA 95616


    mskent@ucdavis.edu

       

    Research Focus

    Clinical and technical aspects of Radiation Oncology and targeted therapies.

    Specialty Focus

    Radiation Oncology

    Education

    1997 DVM Veterinary Medicine, University of California, Davis, CA
    1988 BA Political Science, Boston University, Boston
    2006 MAS Clinical Research, University of California at Davis, Davis, CA

    Licenses

    Diplomate American College of Veterinary Internal Medicine (Oncology)
    Diplomate American College of Veterinary Radiology (Radiation Oncology)

    Active Research Grants

    Co-Investigator, Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies, William J Murphy (Principal Investigator), NIH

    Co-Investigator, Administrative Supplements for P30 Cancer Center Support Grants (CCSG) to Support Research in Canine Immunotherapy via Collaboration of NCI-Designated Cancer Centers and Veterinary Medical Colleges, Lucky Lara (Principal Investigator), NCI

    Co-Investigator, Development of PET Imaging Biomarkers to Predict Enhanced Glioblastoma Radiotherapy by a Novel H-NOX Oxygen Carrier, Cherry, Zwingenberger, Krotolica (Principal Investigator), NCI

    Most Recent 10 Publications

    • Michael S Kent: Can a commercially available EPID dosimetry system detect small daily patient setup errors for cranial IMRT/SRS? 2017 Hsieh ES, Hansen KS, Kent MS, Saini S, Dieterich S Can a commercially available EPID dosimetry system detect small daily patient setup errors for cranial IMRT/SRS? Pract Radiat Oncol,
    • Michael S Kent: Principles and Applications of Radiation Therapy in Exotic Animals 2017 Kent MS Principles and Applications of Radiation Therapy in Exotic Animals Vet Clin North Am Exot Anim Pract,
    • Michael S Kent: Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs 2017 Rebhun RB, Kass PH, Kent MS, Watson KD, Withers SS, Culp WT, King AM Evaluation of optimal water fluoridation on the incidence and skeletal distribution of naturally arising osteosarcoma in pet dogs Vet Comp Oncol,
    • Michael S Kent: The effect of radiation dose on the onset and progression of radiation-induced brain necrosis in the rat model 2017 Hartl BA, HSW MA, Hansen KS, Perks J, Kent MS, Fragoso RC, Marcu L The effect of radiation dose on the onset and progression of radiation-induced brain necrosis in the rat model International journal of radiation biology,
    • Michael S Kent: IQGAP1 is an oncogenic target in canine melanoma 2017 Lee BH, Neela PH, Kent MS, Zehnder AM IQGAP1 is an oncogenic target in canine melanoma PloS one,
    • Michael S Kent: Prospective comparison of tumor staging using computed tomography versus magnetic resonance imaging findings in dogs with nasal neoplasia: A pilot study 2017 Lux CN, Culp WTN, Johnson LR, Kent M, Mayhew P, Daniaux LA, Carr A, Puchalski S Prospective comparison of tumor staging using computed tomography versus magnetic resonance imaging findings in dogs with nasal neoplasia: A pilot study Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association,
    • Michael S Kent: Factors Affecting Platelet Concentration in Platelet Concentrates from Canine Blood Donors 2017 Raleigh JS, Jandrey KE, Burges J, Kent MS Factors Affecting Platelet Concentration in Platelet Concentrates from Canine Blood Donors Journal of Veterinary Internal Medicine,
    • Michael S Kent: Canine cancer immunotherapy studies: linking mouse and human. 2016 Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WT, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer,
    • Michael S Kent: Never mind the length, feel the quality. 2016 Kent MS Never mind the length, feel the quality. J Small Anim Pract,
    • Michael S Kent: Blocking indolamine-2,3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in Murine Models and spontaneous canine malignancies 2016 Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ Blocking indolamine-2,3-dioxygenase rebound immune suppression boosts antitumor effects of radio-immunotherapy in Murine Models and spontaneous canine malignancies Clin Cancer Res,

    Most Recent 5 Book Chapters

    2014 Kent MS, Seguin B: Oral Tumors, Bonagura JD, Twedt DC, (ed), Current Veterinary Therapy XV, St. Louis, MO. 366-69.

    2012 Bergman PJ, Kent MS, Farese J: Melanoma, Withrow, Vail, (ed), Withrow and MacEwen's Small Animal Clinical Oncology, 5th Edition, St. Lois, MO. 321-33.

    2012 Kent MS, Primas P: Chapter 63, Safe handling and care of patients exposed to radioactive and antineoplastic agents, Burkitt Creedon JM, Davis H, (ed), Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care, 1st Edition, Ames, Iowa. 814-20.

    2008 Holmberg BJ, Kent MS: Ocular neoplasia, Bonagura JD, Twedt DC, (ed), Kirk's Current Veterinary Therapy XIV, St. Louis. 1153-7.